CapsoVision (CV) Change in Accured Expenses (2024 - 2025)
CapsoVision recorded quarterly Change in Accured Expenses of -$92000.0 in Q4 2025, down 107.66% quarter-over-quarter from $1.2 million in Q3 2025, and up 86.57% year-over-year from -$49311.4 in Q4 2024.
CapsoVision's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at -$92000.0 for Q4 2025.
- In Q4 2025, Change in Accured Expenses rose 86.57% year-over-year to -$92000.0; the TTM figure through Dec 2025 stood at -$404000.0 (changed N/A YoY), while the FY2025 annual figure was $2.1 million, up 1143.14% from the prior year.
- Change in Accured Expenses came in at -$92000.0 for Q4 2025 at CapsoVision, down from $1.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q3 2025 to a low of -$828000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | -92,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92,000.00 |
| Dec 31, 2025 | -92,000.00 |
| Sep 30, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Dec 31, 2024 | -685,000.00 |
| Dec 31, 2024 | -685,000.00 |
| Sep 30, 2024 | -828,000.00 |
| Sep 30, 2024 | -828,000.00 |